A recent article in Frontiers in Neuroscience looks at the findings of Theoharis C. Theoharides, Julia M. Stewart, Erifili Hatziagelaki and Gerasimos Kolaitis relating to the effect of luteolin on brain “fog”.
Brain “fog” is a constellation of symptoms that include reduced cognition, inability to concentrate and multitask, as well as loss of short and long term memory. A broad range of people affected by conditions such as autism spectrum disorders (ASDs), celiac disease, chronic fatigue syndrome, fibromyalgia, mastocytosis, and postural tachycardia syndrome (POTS), and other neuropsychiatric disorders are affected by it.
The article, which can be read in full, goes on to discuss the recent findings that the immune system and inflammation are increasingly implicated in neuropsychiatric diseases. You can find more articles on brain fog here.